Detection of C-MYC oncogene translocation and copy number change in the normal-dysplasia-carcinoma sequence of the larynx by fluorescence in situ hybridization

被引:8
|
作者
Liu, Yu [1 ,2 ]
Gong, Li-Ping [2 ]
Dong, Xiao-Li [2 ]
Liu, Hong-Gang [1 ]
机构
[1] Capital Med Univ, Dept Pathol, Beijing Tongren Hosp, Beijing 100730, Peoples R China
[2] Capital Med Univ, Dept Pathol, Beijing 100069, Peoples R China
基金
中国国家自然科学基金;
关键词
fluorescent in situ hybridization; laryngeal carcinoma; dysplasia; C-MYC; copy number change; SQUAMOUS-CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; TISSUE MICROARRAY ANALYSIS; PARAFFIN-EMBEDDED TISSUE; CHROMOSOMAL-ABNORMALITIES; GENE AMPLIFICATION; TUMOR PROGRESSION; MOLECULAR-BIOLOGY; HEAD; NECK;
D O I
10.1002/dc.22879
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The aim of this study was to determine the translocation and copy number change of the C-MYC gene in patients with laryngeal dysplasia and laryngeal squamous cell carcinoma (LSCC), and to evaluate the prevalence of such expression in relation to the normal-dysplasia-carcinoma sequence. Fluorescent in situ hybridization (FISH) was applied on formalin-fixed paraffin-embedded blocks of 93 laryngeal lesion specimens (14 normal epithelium, 15 mild dysplasia, 18 moderate dysplasia, 16 severe dysplasia, 9 carcinoma in situ, and 21 invasive carcinoma). C-MYC translocation was not observed in all laryngeal tissue. The high frequency for C-MYC copy-number increased (100%) in invasive carcinoma: 57.14% amplifications and 42.86% gains, and the positive rate of C-MYC amplification and copy-number change increased with the increasing severity of laryngeal lesions (P < 0.0001). The results suggest that C-MYC may be activated by gain/amplification in LSCC and precancerous lesions. Thus, C-MYC may play an important role in promoting LSCC progression, and early FISH detection of C-MYC may be exploited to set a screening test for laryngeal dysplasia. Diagn.Cytopathol. 2013. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:515 / 519
页数:5
相关论文
共 29 条
  • [21] c-myc gene amplification and chromosomal anomalies in prostatic intraepithelial neoplasia and stage D1 carcinoma by fluorescence in situ hybridization
    Qian, J
    Bostwick, DG
    Jenkins, RB
    LABORATORY INVESTIGATION, 1996, 74 (01) : 463 - 463
  • [22] Copy number gains of chromosome 17 identified by dual in situ hybridization in non-small cell lung cancer tissue correlate with overexpression of c-Myc
    Sunpaweravong, Patrapim
    Thongwatchara, Patcharaporn
    Chotipanvithayakul, Rassamee
    Sangkhathat, Surasak
    Thongsuksai, Paramee
    TRANSLATIONAL CANCER RESEARCH, 2022, : 1033 - 1044
  • [23] Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization
    Shimada, M
    Imura, J
    Kozaki, T
    Fujimori, T
    Asakawa, S
    Shimizu, N
    Kawaguchi, R
    ONCOLOGY REPORTS, 2005, 13 (04) : 633 - 641
  • [24] c-MYC, RB-1, TP53, and centromere 8 and 17 copy number in B-cell non-Hodgkin's lymphomas assessed by dual-color fluorescence in situ hybridization
    Galteland, E
    Holte, H
    Stokke, T
    CYTOMETRY, 1999, 38 (02): : 53 - 60
  • [25] Comparative and multimodal analysis of the EGFR, HER2, c-MYC, and MET copy number alteration using in situ hybridization in Korean colorectal cancer patients with integration of array-based copy number data from The Cancer Genome Atlas
    Kwak, Y.
    Yun, S.
    Nam, S. K.
    Seo, A. N.
    Lee, K. S.
    Oh, H-K.
    Kim, D. W.
    Kang, S. B.
    Kim, W. H.
    Lee, H. S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [26] Detection of trisomy 8 in Philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement
    Oudat, R
    Khan, Z
    Glassman, AB
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2001, 31 (01): : 68 - 74
  • [27] In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme:: Correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIα protein expression
    Miracco, C
    De Santi, MM
    Luzi, P
    Lalinga, AV
    Laurini, L
    De Nisi, MC
    Angeloni, G
    Brogi, M
    Cardone, C
    Carducci, A
    Arcuri, F
    Tosi, P
    Rubino, G
    Pirtoli, L
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (06) : 1529 - 1535
  • [28] Comparison between in situ hybridization and digital polymerase chain reaction methods for detecting c-MYC gene copy number gain in tissue and cell-free plasma samples of colorectal cancer patients
    Seo, Soo Hyun
    Lee, Kyu Sang
    Nam, Soo Kyung
    Park, Kyoung Un
    Oh, Heung-Kwon
    Kim, Duck-Woo
    Kang, Sung-Bum
    Lee, Hye Seung
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIα genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization
    Murthy, SK
    Magliocco, AM
    Demetrick, DJ
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2005, 129 (01) : 39 - 46